Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study

被引:2
|
作者
Jiang, Zhi-Hui [1 ]
Aierken, Abudula [1 ]
Wu, Ting-Ting [1 ]
Zheng, Ying-Ying [1 ]
Ma, Yi-Tong [1 ]
Xie, Xiang [1 ]
机构
[1] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China
来源
BMJ OPEN | 2023年 / 13卷 / 04期
基金
中国国家自然科学基金;
关键词
Coronary heart disease; Coronary intervention; Cardiology; Myocardial infarction; GERIATRIC MEDICINE; BLOOD-PRESSURE; HEART-RATE; ARTERY-DISEASE; IMPACT; EXERCISE;
D O I
10.1136/bmjopen-2022-067951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Previous studies have suggested that heart rate and blood pressure play important roles in the development of adverse outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). However, the relationship between the rate pressure product (RPP) and long-term outcomes has rarely been investigated. This study investigated the effects of RPP on the clinical outcomes of patients with CAD who underwent PCI. Design In this study, a total of 6015 patients with CAD were enrolled. All patients were from the CORFCHD-PCI (Clinical Outcomes and Risk Factors of Patients with Coronary Heart Disease after PCI) Study. They were divided into two groups according to RPP (RPP <10269, n=4018and RPP >= 10269, n=1997). In addition, the median follow-up time was 32 months. Participants Data was obtained from 6050 patients with CAD who underwent PCI at the First Affiliated Hospital of Xinjiang Medical University from January 2008 to December 2016. Primary and secondary outcome measures The primary endpoint was long-term mortality, including all-cause mortality (ACM) and cardiac mortality (CM). The secondary endpoints were major adverse cardiovascular events (MACEs) and major adverse cardiovascular and cerebrovascular events (MACCEs). Results We found that there were significant differences between the two groups in the incidence of ACM, CM, MACCEs and MACEs (all p<0.05). Among the patients with CAD having ACM, CM, MACCEs and MACEs, the mean survival time of the low-value group was significantly higher than that of the high-value group. Multivariate Cox regression analyses showed that RPP was an independent predictor for ACM (HR=1.605, 95% CI: 1.215-2.120, p=0.001), CM (HR=1.733, 95%CI: 1.267-2.369, p=0.001), MACCEs (HR=1.271, 95%CI: 1.063-1.518, p=0.008) and MACEs (HR=1.315, 95%CI: 1.092-1.584, p=0.004) in patients with stable CAD. On the other hand, there was no significant correlation between the RPP and the adverse outcomes in patients with acute coronary syndrome. Conclusion In summary, RPP is an independent predictor of long-term prognosis in patients with CAD who underwent PCI. A higher baseline RPP before PCI increased the risk of adverse outcomes. Compared with heart rate and blood pressure alone, RPP has a higher predictive value for adverse clinical outcomes.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study
    Zheng, Ying-Ying
    Wu, Ting-Ting
    Chen, You
    Hou, Xian-Geng
    Yang, Yi
    Xie, Xiang
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (06) : 1021 - 1030
  • [2] Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention
    Zhang, Zeng-Lei
    Guo, Qian-Qian
    Tang, Jun-Nan
    Zhang, Jian-Chao
    Cheng, Meng-Die
    Song, Feng-Hua
    Liu, Zhi-Yu
    Wang, Kai
    Jiang, Li-Zhu
    Fan, Lei
    Yue, Xiao-Ting
    Bai, Yan
    Dai, Xin-Ya
    Zheng, Ru-Jie
    Zheng, Ying-Ying
    Zhang, Jin-Ying
    BIOSCIENCE REPORTS, 2021, 41 (07)
  • [3] Long-term cardiovascular outcomes after percutaneous coronary intervention in patients with systemic sclerosis
    Hirose, Kazutoshi
    Kiriyama, Hiroyuki
    Minatsuki, Shun
    Nagae, Yugo
    Furusawa, Tatsuki
    Hiruma, Takashi
    Kobayashi, Atsushi
    Sato, Masataka
    Sawano, Shinnosuke
    Kamon, Tatsuya
    Shinohara, Hiroki
    Miura, Mizuki
    Saito, Akihito
    Kodera, Satoshi
    Ishida, Junichi
    Takeda, Norifumi
    Morita, Hiroyuki
    Komuro, Issei
    Takeda, Norihiko
    IJC HEART & VASCULATURE, 2025, 57
  • [4] Central aortic pressure and long-term outcome in hypertensive patients undergoing percutaneous coronary intervention
    Wu, Han-Ping
    Lin, Mao-Jen
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Elevation of biomarkers and long-term outcome after percutaneous coronary intervention
    Slimani, Alisson
    Hanet, Claude
    Jamart, Jacques
    Gabriel, Laurence
    Guedes, Antoine
    Dangoisse, Vincent
    Galanti, Laurence M.
    Schroeder, Erwin
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (11) : 1116 - 1120
  • [6] Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study
    Rao, Chongyou
    Zhong, Qin
    Wu, Rilige
    Li, Zongren
    Duan, Yongjie
    Zhou, You
    Wang, Chi
    Chen, Xu
    Wang, Ruiqing
    He, Kunlun
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01)
  • [7] EVALUATION OF LONG-TERM ADVERSE CARDIOVASCULAR EVENTS RISK AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Vershinina, E. O.
    Repin, A. N.
    KARDIOLOGIYA, 2018, 58 : 45 - 52
  • [8] Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention
    Akashi, Naoyuki
    Matoba, Tetsuya
    Kohro, Takahide
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Imai, Yasushi
    Kario, Kazuomi
    Kiyosue, Arihiro
    Mizuno, Yoshiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Ishii, Masanobu
    Nakamura, Taishi
    Tsujita, Kenichi
    Sato, Hisahiko
    Fujita, Hideo
    Nagai, Ryozo
    CLIDAS Res Grp
    CIRCULATION JOURNAL, 2023, 87 (06) : 775 - 782
  • [9] Predicting Long-Term Bleeding After Percutaneous Coronary Intervention
    Sharma, Praneet K.
    Chhatriwalla, Adnan K.
    Cohen, David J.
    Jang, Jae-Sik
    Baweja, Paramdeep
    Gosch, Kensey
    Jones, Philip
    Bach, Richard G.
    Arnold, Suzanne V.
    Spertus, John A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 (02) : 199 - 206
  • [10] Effect of statin on long-term outcomes in persistent tobacco users receiving percutaneous coronary intervention: A longitudinal, retrospective cohort study
    Lin, Mao-Jen
    Lin, Hau-De
    Cai, Chuan-Zhong
    Chuang, Ming-Jen
    Yang, Feng-Ching
    Chiang, Kuo Feng
    Wu, Han-Ping
    MEDICINE, 2024, 103 (45) : e40463